Navigation Links
Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
Date:2/20/2008

Epilepsy Sales Increase Significantly

HOUSTON, Feb. 20 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced results for the fiscal year 2008 third quarter ended January 25, 2008.

Financial highlights

Net sales

Net sales for the third quarter of fiscal 2008 were $29.3 million, compared to $28.9 million in the second quarter of fiscal 2008 and $31.7 million in the third quarter of fiscal 2007. Net sales for the nine months ended January 25, 2008 were $87.3 million, compared to $99.5 million in the comparable period of the prior year; net sales in fiscal 2008 attributable to the epilepsy indication of $82.6 million have increased by 9.4% over fiscal 2007.

U.S. net sales for the third quarter of fiscal 2008 declined to $22.2 million, compared with $26.6 million in the comparable period of fiscal 2007. Overall, U.S. net sales declined due to the continued reduction in the number of VNS Therapy Systems attributable to treatment-resistant depression ("TRD"), following both the preliminary and final non-coverage determinations by the Centers for Medicare and Medicaid Services in February 2007 and May 2007, respectively; however, net sales attributable to the epilepsy indication increased by approximately 13% over the comparable prior year quarter.

International net sales increased by 36% to a record $6.9 million, up from the $5.1 million reported in the third quarter of fiscal 2007, due primarily to unit growth of 20%, the impact of foreign currency movements and improved pricing.

Net sales include $167,000 relating to the license fee of $9.5 million received during the third quarter. It is anticipated that this license fee will be recognized at a quarterly rate of $373,000 through the end of fiscal 2014. The unamortized amount is reflected as deferred revenue in long-term liabilities.

Gross margin

The gross margin for the third quarter of fiscal 2008 represente
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Cyberonics Licenses Obesity-Related Patents
2. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... widespread discrimination and health inequities. Since 2012, Massachusetts law has provided legal protections ... and business. However, the law does not protect against discrimination based on gender ...
(Date:7/29/2015)... ... ... Potomac Pilates, an elite Washington, D.C. metro area-based Pilates studio, is excited ... Potomac Pilates. On Thursday, July 30, Potomac Pilates will unveil its new name, ... will continue to offer the same classes and personal experiences their clients know and ...
(Date:7/29/2015)... Park, Pa. (PRWEB) , ... July 29, 2015 ... ... education services for autism. Parents, educators and service providers of children living with ... practices to better serve the growing demographic. , The National Autism Conference ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... Commission) CCM® credential for a five-year period, expiring November 30, 2019, during its ... credential by submitting an application demonstrating the program’s compliance with the NCCA’s Standards ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to the Miami ... or alcohol addiction and mental health disorders. Acu-detox may begin taking off in the ... from drug and alcohol addiction. Although acupuncture is not a new practice, it is ...
Breaking Medicine News(10 mins):Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3
... injection leads to dependent behavior , , THURSDAY, May 28 ... role in the disrupted functioning of the brain,s reward ... says a new study. , "If we can understand ... abuse, it could potentially suggest ways to medically counteract ...
... Digital media are changing the environment for communicating health ... New Media Landscape," University of Missouri researchers examine how ... care in the United States. Effective health communication can ... as reduce inequities in people,s access to health information ...
... Network Global Logistics (NGL), a premier provider of mission critical transportation, ... its global network of forward stocking locations (FSL,s). , ... ... a premier provider of mission critical transportation, service/spare parts logistics ...
... Jr., President & Chief Executive Officer of Concurrent Technologies Corporation ... been awarded a contract with a potential value of $90,000 ... this announcement to kick off Johnstown,s Annual Showcase for Commerce. ... Centers for Disease Control and Prevention (CDC) with Information Technology ...
... your teeth healthy. , People, who suffer from gum ... reduced their arthritic pain, number of swollen joints and the ... Researchers from the Case Western Reserve University School of ... new intervention for arthritis in the Journal of Periodontology ...
... donor factors that could affect outcomes for liver transplant ... found that donor steatosis, or fat in the liver, ... in recipients with or without HCV. However, transplants from ... affect the outcomes of HCV-positive recipients more than recipients ...
Cached Medicine News:Health News:MU researchers offer insights for advancing health communication through digital media 2Health News:NGL Expands Global Network to Service Parts Logistics Customers 2Health News:NGL Expands Global Network to Service Parts Logistics Customers 3Health News:Concurrent Technologies Corporation Awarded Contract to Support the Centers for Disease Control and Prevention with Readiness Efforts 2Health News: Treating gum disease helps rheumatoid arthritis sufferers 2Health News:Some donor factors affect outcomes for HCV-positive liver transplant recipients 2
(Date:7/29/2015)... , July 29, 2015  Ortho-Clinical Diagnostics, Inc. ... assays under development. The assays address a range of ... injury and cardiac troponin I. The scientific posters will ... Chemistry Annual Meeting to be held July 26 - ... "Ortho Clinical Diagnostics is emerging stronger than ...
(Date:7/29/2015)... July 29, 2015  The Perinatal Quality Foundation ... understanding of the advantages, limitations and clinically appropriate ... other diagnostic tests for pregnant women and their ... the world,s leading provider of diagnostic information services, ... initiative, through a grant. Through ...
(Date:7/29/2015)... 29, 2015  ViaCyte, Inc., a privately-held regenerative medicine company with ... diabetes in clinical trials, today announced the opening of a second ... S afety, T olerability, and E fficacy of VC-01™ ... new site, which is the first in Canada ... Edmonton , Alberta.  The lead ...
Breaking Medicine Technology:Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 2Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 3Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 4ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4
... , INDIANAPOLIS, Nov. 16 AMD LASERS, the world ... announced the addition of Bart Waclawik as Chief Operating ... be responsible for daily global operations, procurement, production, quality ... he will lead the engineering effort on the next-generation ...
... , PHILADELPHIA, Nov. 16 Shire plc ... biopharmaceutical company, announced new study results on INTUNIV ... Child and Adolescent Psychopharmacology. In this open-label safety study, ... of INTUNIV and amphetamine or methylphenidate relative to what was observed ...
Cached Medicine Technology:AMD LASERS Announces the Addition of Bart Waclawik, New Chief Operating Officer 2Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants 2Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants 3Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants 4Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants 5Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants 6Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants 7
... This combination of Penicillin, Steptomycin, and ... common forms of cell culture contamination; ... yeast, and fungi; when used at ... sterile solution is a combination of ...
All BioWhittaker Cell Culture Reagent and Buffer products are manufactured in accordance with cGMP regulations and are cell culture tested to assure compatibility. , Typical Properties, Sterility : ...
...
... to buff-colored powder Activity: >=590g of gentamicin/mg (dry basis) ... Limit of Methanol: Specific Rotation (25C): +107 to ... 2 O): 3.5 to 5.5 Loss on drying: ... 25-50% C 2 + C 2a : 25-55% ...
Medicine Products: